The daily business briefing: February 1, 2017

U.S. stocks seek footing as rally cools over Trump concerns, Trump calls for drug companies to lower prices, and more

President Trump meets with pharmaceutical representatives
(Image credit: Ron Sachs - Pool/Getty Images)

1. U.S. stocks regroup after retreating further from 20,000 level

The Dow Jones Industrial Average on Tuesday dropped further below the 20,000 threshold it reached for the first time last week, as U.S. stocks, which surged after the election, continued to lose momentum as uncertainty bubbled up over President Trump's next moves. The Dow fell by 107 points, or 0.5 percent, to 19,864. The S&P 500 index dropped by 2 points, or 0.1 percent, and the Nasdaq Composite edged up by 1 point, or 0.02 percent. Stock futures bounced back early Wednesday, pointing to a rise at the opening bell, led by gains for tech giants after Apple reported earnings that beat expectations.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.